We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.72%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$16.2B
AUM Growth
+$1.16B
(+7.7%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
13.75%
Holding
668
New
158
Increased
115
Reduced
144
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$255M |
| 2 |
Broadcom
AVGO
|
+$180M |
| 3 |
AstraZeneca
AZN
|
+$147M |
| 4 |
Intuitive Surgical
ISRG
|
+$142M |
| 5 |
TE Connectivity
TEL
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$441M |
| 2 |
AerCap
AER
|
+$184M |
| 3 |
Western Digital
WDC
|
+$157M |
| 4 |
Akamai
AKAM
|
+$127M |
| 5 |
EPAM Systems
EPAM
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.67% |
| 2 | Consumer Discretionary | 14.19% |
| 3 | Industrials | 13.31% |
| 4 | Healthcare | 12.83% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
351
Boundless Bio
BOLD
$64.1M
| $3.56M | 0.02% |
+250,000
| New | +$3.56M |
|
|
ETNB
352
DELISTED
89bio
ETNB
| $3.49M | 0.02% |
300,000
-283,187
| -49% | -$3.14M |
|
353
PSQ Holdings
PSQH
$14M
| $3.4M | 0.02% |
42,142
+1,808
| +4% | +$134K |
|
354
Precision BioSciences
DTIL
$206M
| $3.39M | 0.02% |
+250,000
| New | +$3.06M |
|
355
Latham Group
SWIM
$860M
| $3.22M | 0.02% |
812,502
-200,000
| -20% | -$570K |
|
356
EyePoint Inc
EYPT
$1.13B
| $3.06M | 0.02% |
147,837
-39,003
| -21% | -$966K |
|
357
Peloton Interactive
PTON
$2.42B
| $3M | 0.02% |
+700,100
| New | +$3.46M |
|
|
ATYR
358
aTyr Pharma
ATYR
$51.9M
| $2.94M | 0.02% |
1,505,555
-950,000
| -39% | -$1.66M |
|
359
Hexcel
HXL
$7.63B
| $2.92M | 0.02% |
40,071
-23,573
| -37% | -$1.7M |
|
360
Amylyx Pharmaceuticals
AMLX
$2.53B
| $2.86M | 0.02% |
+1,008,607
| New | +$13.2M |
|
361
CALL
Elutia
ELUT
$36M
| $2.81M | 0.02% |
893,445
| – | – |
|
|
RGLS
362
DELISTED
Regulus Therapeutics
RGLS
| $2.68M | 0.02% |
+937,500
| New | +$1.53M |
|
|
AUNA
363
Auna
AUNA
$390M
| $2.66M | 0.02% |
+250,000
| New | +$2.57M |
|
|
ELME
364
Elme Communities
ELME
$144M
| $2.65M | 0.02% |
+190,331
| New | +$2.65M |
|
365
Ichor Holdings
ICHR
$2.43B
| $2.51M | 0.02% |
+65,000
| New | +$2.52M |
|
366
Reddit
RDDT
$30.5B
| $2.47M | 0.02% |
+50,000
| New | +$2.74M |
|
367
STAAR Surgical
STAA
$1.25B
| $2.46M | 0.02% |
+64,185
| New | +$2.09M |
|
368
Monolithic Power Systems
MPWR
$67.9B
| $2.31M | 0.01% |
3,410
-29,610
| -90% | -$19.8M |
|
369
CALL
Immatics
IMTX
$1.33B
| $2.26M | 0.01% |
215,223
| – | – |
|
370
Five Star Bancorp
FSBC
$1.13B
| $2.25M | 0.01% |
+100,000
| New | +$2.4M |
|
|
HELP
371
Cybin Inc
HELP
$620M
| $2.23M | 0.01% |
142,233
-7,325
| -5% | -$106K |
|
372
Achieve Life Sciences
ACHV
$685M
| $2.14M | 0.01% |
+471,000
| New | +$2.09M |
|
373
Aquestive Therapeutics
AQST
$538M
| $2.13M | 0.01% |
+500,000
| New | +$1.66M |
|
374
Treace Medical Concepts
TMCI
$304M
| $2.05M | 0.01% |
156,795
-25,317
| -14% | -$338K |
|
375
MeiraGTx Holdings
MGTX
$1.21B
| $2M | 0.01% |
330,182
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2024 Portfolio in Review
As of Q1 2024, Alyeska Investment Group held 668 positions worth $16.2B, up 7.7% from $15.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group's Q1 2024 filing shows 158 new, 115 increased, 144 reduced and 223 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,783,151 shares worth $269M. The largest sale was Meta Platforms (Facebook), an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q1 2024 buy was Alphabet (Google) Class A: 1,783,151 shares worth $269M.
- Alyeska Investment Group added most to AstraZeneca in Q1 2024, an estimated $147M increase.
- Alyeska Investment Group's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $441M.
- Alyeska Investment Group fully exited Akamai in Q1 2024, selling an estimated $127M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $16.2B portfolio in Q1 2024.
- Alyeska Investment Group opened 158 new positions and closed 223 in Q1 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $16.2B.
Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.